Drug Trial Radar · NCT06431893
A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
100
Planned (sponsor's estimate)
Start
Apr 30, 2024
Primary completion
Aug 2030
Study completion Aug 2030
Sponsor
- Lead sponsor
- Travere Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this long-term extension (LTE) study is to evaluate the safety and efficacy of pegtibatinase in patients with classical homocystinuria (HCU). Patients who are active in the Phase 1/2 COMPOSE study or those who complete the 24 weeks of blinded treatment in the Phase 3 HARMONY are eligible to participate. Participants will be in this clinical study for a minimum of 108 weeks including: a treatment period of up to 104 weeks a 4-week safety follow-up period
Conditions
- Homocystinuria
Interventions
PegtibatinaseDrug
Pegtibatinase BIW
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment-emergent AEsTime frame: Week 1 - Week 108
- HypermethioninemiaTime frame: Week 1 - Week 108
- HypomethioninemiaTime frame: Week 1 - Week 108
- Dietary Protein RescueTime frame: Week 1 - Week 108
Locations
52 sites in 14 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
Yale University School of Medicine
New Haven, Connecticut
Emory University
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Maine Health Pediatric Specialty Care
Portland, Maine
Uncommon Cures
Chevy Chase, Maryland
Icahn School of Medicine at Mount Sinai
New York, New York
Science 37 - Virtual Site
Morrisville, North Carolina
Oregon Health and Science University
Portland, Oregon
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
Utah Health - The University of Utah Primary Children's Hospital
Salt Lake City, Utah
Royal Adelaide Hospital
Adelaide, Australia
Royal Children's Hospital Melbourne
Parkville, Australia
Westmead Hospital
Westmead, Australia
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Belgium
Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Necker-Enfants Malades
Paris, France
CHRU Hôpitaux de Tours - Hôpital Bretonneau
Tours, France
Centre Hospitalier Régional Universitaire de Nancy (CHRU) - Hopitaux de Brabois - Hôpital d'enfants
Vandœuvre-lès-Nancy, France
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitätsklinikum Münster
Münster, Germany
Children's Health Ireland (CHI) at Temple Street
Dublin, Ireland
Ospedale Pediatrico Giovanni XXIII
Bari, Italy
IRCCS Istituto Giannina Gaslini
Genova, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Policlinico di Milano)
Milan, Italy
Fondazione IRCCS San Gerardo Dei Tintori - Ospedale San Gerardo
Monza, Italy
Azienda Ospedaliera di Padova
Padova, Italy
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Poland
Instytut Matki i Dziecka
Warsaw, Poland
Instytut Pomnik-Centrum Zdrowia Dziecka
Warsaw, Poland
Unidade Local de Saúde de Coimbra, EPE - Hospitais da Universidade de Coimbra
Coimbra, Portugal
Unidade Local de Saúde de Santa Maria, EPE - Hospital de Santa Maria
Lisbon, Portugal
Unidade Local de Saúde de São João, EPE - Hospital São João
Porto, Portugal
Hamad General Hospital
Doha, Qatar
Sidra Hospital
Doha, Qatar
King Abdullah International Medical Research Center
Riyadh, Saudi Arabia
King Faisal Specialist Hospital and Research Centre (KFSHRC) - Riyadh
Riyadh, Saudi Arabia
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.